Feature

ABIM to allow do-overs for all subspecialties with Knowledge Check-In


 

The American Board of Internal Medicine is extending its “no consequence” Knowledge Check-In attempt to all subspecialties.

ABIM previously announced that, beginning in 2018, physicians taking the Knowledge Check-In in 2018 would get another chance to take it in 2 years if they were unsuccessful, even if they were due to pass the maintenance of certification (MOC) exam later that year. In 2018, Knowledge Check-Ins will be offered in internal medicine and nephrology.

“Based on feedback ABIM has received from the physician community, we are happy to let you know that we are extending this policy to include all other internal medicine subspecialties in the future,” ABIM said in a Dec. 4 announcement on its website. “This means that if a physician takes the Knowledge Check-In in the first year it is offered in their subspecialty and is unsuccessful, they will get at least one additional opportunity to take and pass it 2 years later.”

The Knowledge Check-In is an alternative to the traditional MOC process, and is administered every 2 years rather than the standard decade between MOC exams. ABIM noted that a single failure on a Knowledge Check-In will not result in a status change to a physician’s certification status.

Separately, ABIM also announced that it will continue to make practice assessment activities (part IV of the MOC program) a part of the portfolio of options that can be used to satisfy MOC requirements.

“Our intent is to support physicians completing MOC activities that are most meaningful to their practice, including those that enhance and improve medical knowledge, as well as many existing quality improvement activities, and those that blend both,” ABIM said in its announcement.

Recommended Reading

MACRA Monday: Elder maltreatment screening
MDedge Hematology and Oncology
CMS to enlist Medicare Part D plans to combat opioid abuse
MDedge Hematology and Oncology
FDA grants orphan drug status to rofecoxib for hemophilic arthropathy
MDedge Hematology and Oncology
Marketplace confusion opens door to questions about skinny plans
MDedge Hematology and Oncology
HealthCare.gov seeing more action this fall
MDedge Hematology and Oncology
Drug prices a key focus of Senate HELP examination of Azar nomination
MDedge Hematology and Oncology
5 big ways the tax bill could affect health policy
MDedge Hematology and Oncology
FDA: Puerto Rico’s medical supply shortage issues continue
MDedge Hematology and Oncology
CMS looking to evolve QPP to measure outcomes, not processes
MDedge Hematology and Oncology
Medicare pay cut may loom in wake of tax bill passage
MDedge Hematology and Oncology